John Overdeck’s Colgate-Palmolive CL Stock Holding History

John Overdeck’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-21,300	Closed	-$1.82M	–	2927
2021 Q4	$1.82M	Sell	21,300 -9,800	-32%	-$765K	﹤0.01%	2004
2021 Q3	$2.35M	Buy	31,100 +23,400	+304%	+$1.86M	0.01%	1840
2021 Q2	$626K	Sell	7,700 -11,200	-59%	-$916K	﹤0.01%	2901
2021 Q1	$1.49M	Buy	18,900 +11,700	+163%	+$917K	﹤0.01%	1944
2020 Q4	$616K	Buy	7,200 +1,100	+18%	+$91K	﹤0.01%	2350
2020 Q3	$471K	Sell	6,100 -11,000	-64%	-$839K	﹤0.01%	2292
2020 Q2	$1.25M	Buy	+17,100	New	+$1.21M	0.01%	1376
2020 Q1	–	Sell	-20,300	Closed	-$1.4M	–	3177
2019 Q4	$1.4M	Buy	20,300 +9,300	+85%	+$634K	﹤0.01%	1882
2019 Q3	$809K	Sell	11,000 -4,000	-27%	-$290K	﹤0.01%	2162
2019 Q2	$1.07M	Buy	+15,000	New	+$1.06M	﹤0.01%	1885
2019 Q1	–	Sell	-8,400	Closed	-$500K	–	3067
2018 Q4	$500K	Buy	+8,400	New	+$526K	﹤0.01%	2098
2016 Q4	–	Sell	-109,200	Closed	-$8.1M	–	3134
2016 Q3	$8.1M	Buy	109,200 +79,200	+264%	+$5.85M	0.03%	646
2016 Q2	$2.2M	Sell	30,000 -6,000	-17%	-$427K	0.01%	1214
2016 Q1	$2.54M	Buy	36,000 +14,000	+64%	+$931K	0.01%	1045
2015 Q4	$1.47M	Buy	+22,000	New	+$1.46M	0.01%	1257

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

John Overdeck's CL Position: Q2 2026 in Review

John Overdeck increased its Colgate-Palmolive (CL) stake by 1,202% in Q2 2026, buying an estimated $4.94M and bringing the position to 61,200 shares worth $5.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

John Overdeck first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $210M in Q1 2023. 2,007 funds tracked by Wall St. Rank hold CL as of Q2 2026.

John Overdeck held 61,200 shares of Colgate-Palmolive worth $5.61M as of Q2 2026.
John Overdeck bought 56,500 Colgate-Palmolive shares in Q2 2026, an estimated $4.94M.
Colgate-Palmolive made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2030 holding.
John Overdeck first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
John Overdeck's Colgate-Palmolive position peaked at $210M in Q1 2023.
2,007 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.